Does the who and how of surgery in bladder cancer matter?

Journal of Clinical Oncology

Volumn 22, Issue 14, 2004, Pages 2762-2764

  Lange, Paul H ^a   Lin, Daniel W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

BLADDER CANCER; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLON CANCER; CYSTECTOMY; EDITORIAL; HEALTH CARE QUALITY; HUMAN; PENIS CANCER; PRIORITY JOURNAL; SURGEON; SURGICAL TECHNIQUE; TESTIS CANCER; TREATMENT OUTCOME; BLADDER TUMOR; CANCER STAGING; LYMPHADENECTOMY; METHODOLOGY; MORTALITY; NOTE; PATHOLOGY; STATISTICS;

CYSTECTOMY; HUMANS; LYMPH NODE EXCISION; NEOPLASM STAGING; URINARY BLADDER NEOPLASMS;

EID: 4344681552     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.03.936     Document Type: Editorial

References (21)

1. Shahian DM: Improving cardiac surgery quality-volume, outcome, progress. JAMA 291:246-248, 2003
2. Begg CB, Cramer LD, Hoskins WJ, et al: Impact of hospital volume on operative mortality for major cancer surgery. JAMA 280:1747-1751, 1998
3. Begg CB, Riedel ER, Bach PB, et al: Variations in morbidity after radical prostatectomy. N Engl J Med: 346:1138-1144, 2002
4. Fisher B: The evolution of paradigms for the management of breast cancer: A personal perspective. Cancer 52:2371-2383, 1992
5. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002
6. Pantel K, Cote RJ, Fodstad O: Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 91:1113-1124, 1999
7. Cohen AM, Tremiterra S, Candela F, et al: Prognosis of node-positive colon cancer. Cancer 67:1859-1861, 1991
8. Srinivas V, Morse MJ, Herr HW, et al: Penile cancer: Relation of extent of nodal metastasis to survival. J Urol 137:880-882, 1987
9. Donohue JP, Thornhill JA, Foster RS, et al: The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: The Indiana University experience (1965-1989). J Urol 153:85-89, 1995
10. Herr HW, Faulkner JR, Grossman HB, et al: Surgical factors impact bladder cancer outcomes: A cooperative group report. J Clin Oncol 22:2781-2789, 2004
11. Soloway MS, Lopez AE, Patel J, et al: Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy. Cancer 73:1926-1931, 1994
12. Stein JP, Lieskovsky G, Cote R, et al: Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol: 19:666-675, 2001
13. Leissner J, Hohenfellner R, Thuroff JW, et al: Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder: Significance for staging and prognosis. BJU Int 85:817-821, 2000
14. Herr HW, Bochner BH, Dalbagni G, et al: Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167:1295-1298, 2002
15. Grossman HB, Natale RB, Tangen CM, et al: Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349:859-866, 2003
16. Kim H, Steinberg GD: The current status of bladder preservation in the treatment of muscle invasive bladder cancer. J Urol 164:627-632, 2000
17. Le Voyer TE, Sigurdson ER, Hanlon AL: Colon cancer survival is associated with increasing number of lymph nodes analyzed: A secondary survey of intergroup trial INT-0089. J Clin Oncol: 21:2912-2919, 2003
18. Herr HW: Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urol 61:105-108, 2003
19. American College of Surgeons Oncology Group Web site: http:// www.acosog.org
20. Society of Urologic Oncology Web site: http://www. societyofurologiconcology.org
21. Lange PH: Urology in the 21st century: Futuristic musings. Urol 61:681-684, 2003